###begin article-title 0
Localization of phosphatidylinositol phosphate kinase IIgamma in kidney to a membrane trafficking compartment within specialized cells of the nephron
###end article-title 0
###begin p 1
###xml 162 177 162 177 <email xmlns:xlink="http://www.w3.org/1999/xlink">jhc30@cam.ac.uk</email>
Address for reprint requests and other correspondence: J. H. Clarke, Dept. of Pharmacology, Univ. of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK (e-mail: jhc30@cam.ac.uk)
###end p 1
###begin p 2
This document may be redistributed and reused, subject to .
###end p 2
###begin p 3
###xml 976 979 953 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
PIP4Ks (type II phosphatidylinositol 4-phosphate kinases) are phosphatidylinositol 5-phosphate (PtdIns5P) 4-kinases, believed primarily to regulate cellular PtdIns5P levels. In this study, we investigated the expression, localization, and associated biological activity of the least-studied PIP4K isoform, PIP4Kgamma. Quantitative RT-PCR and in situ hybridization revealed that compared with PIP4Kalpha and PIP4Kbeta, PIP4Kgamma is expressed at exceptionally high levels in the kidney, especially the cortex and outer medulla. A specific antibody was raised to PIP4Kgamma, and immunohistochemistry with this and with antibodies to specific kidney cell markers showed a restricted expression, primarily distributed in epithelial cells in the thick ascending limb and in the intercalated cells of the collecting duct. In these cells, PIP4Kgamma had a vesicular appearance, and transfection of kidney cell lines revealed a partial Golgi localization (primarily the matrix of the cis-Golgi) with an additional presence in an unidentified vesicular compartment. In contrast to PIP4Kalpha, bacterially expressed recombinant PIP4Kgamma was completely inactive but did have the ability to associate with active PIP4Kalpha in vitro. Overall our data suggest that PIP4Kgamma may have a function in the regulation of vesicular transport in specialized kidney epithelial cells.
###end p 3
###begin p 4
###xml 140 153 140 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 4
###begin p 5
###xml 0 21 0 21 <sc xmlns:xlink="http://www.w3.org/1999/xlink">polyphosphoinositides</sc>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 716 722 716 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2</italic>
###xml 895 896 895 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 997 998 997 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1000 1002 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 1055 1056 1055 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 1098 1100 1098 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
polyphosphoinositides are quantitatively minor lipid components of cells and are increasingly being recognized as making diverse and important contributions to many aspects of cell physiology, for example, in ion channel regulation, membrane trafficking, cell proliferation, and cytoskeletal rearrangement (for reviews see Refs. 10, 18, 32, 40, 46). Phosphatidylinositol 5-phosphate (PtdIns5P) is the most recent polyphosphoinositide to be found, first identified as the primary substrate for the type II PtdInsP kinases (33). Here these enzymes are referred to as PIP4Ks (consistent with their substrate specificity as PtdIns5P 4-kinases), although it should be noted that gene nomenclature still refers to them as PIP5K2s. As a minor component of cell polyphosphoinositides, it is suggested that PtdIns5P either provides a specific lipid pool for a (minor) localized production of PtdIns(4,5)P2 or that it is a signaling molecule in its own right. Suggested functions include nuclear responses (9, 13), insulin signaling, and protein kinase regulation (5, 22, 31, 38) and phosphatase activation (39).
###end p 5
###begin p 6
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 107 108 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 124 125 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
###xml 380 382 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 384 386 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 428 429 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 431 432 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 434 436 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 498 500 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 547 548 529 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 564 566 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r47">47</xref>
###xml 646 647 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 714 716 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 718 720 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r47">47</xref>
###xml 747 749 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 784 786 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 788 790 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 828 829 810 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
PtdIns5P can be synthesized from PtdIns by a PtdIns 5-kinase (37) or by dephosphorylation from PtdIns(3,5)P2 or PtdIns(4,5)P2 (28, 41-43). The main route of PtdIns5P metabolism is via PIP4Ks, which are represented in vertebrates by three characterized isoforms, alpha, beta, and gamma. PIP4Kalpha is found predominantly in the cytosol and can be recruited to the plasma membrane (15, 45). PIP4Kbeta is localized to the nucleus (3, 7, 36), where there is evidence that it regulates PtdIns5P levels (21), probably in concert with type I PtdIns(4,5)P2 4-phosphatase (47), although it has also been seen to associate with the cytosolic TNF receptor (6). As cellular PtdIns5P levels are modified in response to stress (21, 47), to bacterial infection (28), to receptor-mediated signaling (26, 45), and during cell cycle progression (8), the ability of the PIP4Ks to localize to specific compartments, or to shuttle between them, may be intrinsic to their function.
###end p 6
###begin p 7
###xml 31 33 27 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 134 135 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The third isoform, PIP4Kgamma (19), has not yet been associated with a cellular function, either related to production of PtdIns(4,5)P2 or to the attenuation of PtdIns5P. In the present study, we have extensively characterized the tissue distribution of all of the PIP4K isoforms and found an exceptionally high level of PIP4Kgamma expression in the kidney. We have further investigated the localization within this organ of PIP4Kgamma, using a specific antibody to this isoform, and found that it is remarkably confined to specific cell populations, where it is localized to vesicular structures. Transfection experiments with PIP4Kgamma suggest that these may be derived from the Golgi apparatus. Our results suggest that PIP4Kgamma may be involved in vesicle trafficking in specific kidney cells and that this would imply a specialized function for this enzyme.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
PIP4K cloning.
###end title 9
###begin p 10
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2</italic>
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2A</italic>
###xml 251 258 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2B</italic>
###xml 351 358 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind</italic>
###xml 504 507 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 598 614 598 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 625 631 625 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2</italic>
###xml 845 851 845 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2</italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 598 614 <span type="species:ncbi:562">Escherichia coli</span>
PIP5K2 genes were amplified from a whole human brain marathon-ready cDNA library (Clontech Laboratories, Mountain View, CA) using gene-specific primers (PIP5K2A forward: 5'-ATGGCGACCCCCGGCAACCTAGGGTC-3' and reverse: 5'-TTACGTCAAGATGTGGCCAATAAAGTC-3'; PIP5K2B forward: 5'-ATGTCGTCCAACTGCACCAGCACCAC-3' and reverse: 5'-CTACGTCAGGATGTTGGACATAAAC-3'; and PIP5K2C forward: 5'-ATGGCGTCCTCCTCGGTCCCACCAG-3' and reverse: 5'-TTAGGCAAAGATGTTGGTAATAAAATC-3'). PCR products were cloned, via incorporated HindIII and BamHI restriction sites, into appropriate plasmid vectors. Recombinant protein expressed from Escherichia coli harboring PIP5K2s in pET-32a (Novagen, Madison, WI) was purified using TALON metal affinity resin (Clontech) and cleaved with enterokinase (New England Biolabs, Ipswich, MA). Endotoxin-free plasmid from bacterial clones harboring PIP5K2s in pEGFP-C1 (Clontech) was prepared (DNA extraction kit; Qiagen, Huntsville, AL). All constructs were confirmed by sequencing.
###end p 10
###begin title 11
Cell culture and transfection.
###end title 11
###begin p 12
###xml 544 545 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 109 115 <span type="species:ncbi:9913">bovine</span>
HeLa, HEK 293, COS-7, and NRK cells were maintained in DMEM (GIBCO, Paisley, UK) supplemented with 10% fetal bovine serum, 50 U/ml penicillin, and 50 mug/ml streptomycin. Cells were transiently transfected with plasmid constructs for 24 h with TransFectin reagent (Bio-Rad, Hercules, CA), using the manufacturer's protocol. Cell lysates for immunoprecipitation were made by suspending cells in cold lysis buffer (PBS with 1% Triton X-100, 5 mM EDTA, 5 mM EGTA, and 100 mul/ml Sigma P8340 protease inhibitor cocktail) and centrifuging at 10,000 g for 10 min at 4degreesC.
###end p 12
###begin title 13
Tissue sample preparation.
###end title 13
###begin p 14
###xml 857 858 853 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 947 948 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
###xml 1116 1120 <span type="species:ncbi:10090">mice</span>
Protein and mRNA samples were prepared from adult mouse tissues obtained post mortem and immediately frozen on dry ice after collection. Tissues (50 mg) for mRNA extraction were pulsed in lysing matrix D tubes (Qbiogene) with 1 ml Tri-Reagent (Sigma-Aldrich, Poole, UK) on a Hybaid Ribolyser. Samples were purified (RNeasy kit; Qiagen, and Turbo DNase; Ambion, Austin, TX), and cDNA libraries were constructed by RT-PCR (Sprint Powerscript kit; Clontech). Protein lysates were prepared in RIPA buffer (150 mM sodium chloride, 50 mM Tris pH 7.4, 1 mM EDTA, 1% Triton X-100, 1% deoxycholic acid, and 0.1% SDS) with 10 mM tetrasodium pyrophosphate, 10 mM sodium fluoride, 17.5 mM beta-glycerophosphate, and 100 mul/ml Sigma P8340 protease inhibitor cocktail, using 10-15 strokes in a 5 ml dounce homogenizer. Cell debris was cleared by centrifugation at 2,900 g for 20 min at 4degreesC, and lysates were clarified by further centrifugation at 29,000 g for 45 min at 4degreesC. Kidney tissue was dissected under a binocular microscope to produce cortical and medullary samples. Tissues for immunochemistry from perfused mice were fixed in 4% paraformaldehyde, sectioned on a Leica cryostat at -20degreesC, mounted on slides, and stored at -80degreesC.
###end p 14
###begin title 15
Quantitative PCR.
###end title 15
###begin p 16
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2</italic>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2A</italic>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2B</italic>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 1163 1164 1139 1140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 1273 1279 1249 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2</italic>
###xml 1410 1411 1379 1380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 1456 1457 1425 1426 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 1466 1468 1435 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 1306 1311 <span type="species:ncbi:10090">mouse</span>
Singleplex quantitative PCR was carried out using specific primers for each PIP5K2 gene, designed to the 3'-untranslated region (PIP5K2A forward: 5'-AAGAGTCTGATGCCAAGAACCTGT-3' and reverse: 5'-TGCAGTGCAACTTAAGGATGGTAA-3'; PIP5K2B forward: 5'-CATCCTCACAGAAGAACATGGC-3' and reverse: 5'-CCTGGTCATTCACCGTCTCA-3'; and PIP5K2C forward: 5'-CATCTTCCACTGCTAATGTGTCTCC-5' and reverse: 5'-TTGAGTTATGGCTCTGACTCCTCTCT-3'). Three cDNA libraries were constructed for each tissue tested and analyzed in triplicate. PCR amplification was performed in a 96-well plate using SYBR Green I master mix (Applied Biosystems, Warrington, UK), following the manufacturer's protocol. Reactions were heated (50degreesC for 2 min, 95degreesC for 10 min) and cycled 40 times (95degreesC for 15 sec, 60degreesC for 1 min) on an ABI Prism 7700 sequence detection system (Applied Biosystems). Dissociation curves for each primer set indicated a single product, and no-template controls were negative after 40 cycles. Reactions using RNA as template were negative, showing that the preparations were free from genomic DNA contamination. Primer concentrations were chosen to give threshold cycle (CT) values of 20-25. Validation experiments showed equivalent relative amplification efficiencies between each PIP5K2 gene and a primer set for mouse beta-actin (forward: 5'-GACGATATCGCTGCGCTGGT-3' and reverse: 5'-CCACGATGGAGGGGAATA-3'), and DeltaCT values were analyzed using the comparative CT method (23).
###end p 16
###begin title 17
In situ hybridization.
###end title 17
###begin p 18
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 242 249 242 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 369 371 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 500 502 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 319 324 <span type="species:ncbi:10090">mouse</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
Two oligonucleotide probes were designed to the PIP5K2C sequence, one in the 3'-untranslated region (5'-GACTGGGTGGATTGAGTTATGGCTCTGACTCCTCT-3') and one in the coding sequence (5'-ATAGGAGATAAGGAAACGGCCATCACTGCCTTCAG-3'), which only identified PIP5K2C when BLAT searched against the European Molecular Biology Laboratory mouse database. Probes were 3'-tail-labeled with [35S]dATP (NEN, Hounslow, UK), hybridized with 20-mum mouse tissue sections and autoradiographed for 5 wk, as described previously (12). Slides of interest were dipped in autoradiographic emulsion and after development (12 wk) were counterstained with hematoxylin and eosin, and images were captured using an Axioskop II light microscope.
###end p 18
###begin title 19
Antibody analysis and Western blotting.
###end title 19
###begin p 20
###xml 631 632 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 206 212 <span type="species:ncbi:9986">rabbit</span>
A peptide (amino acids 333-352), unique to the variable region of the mouse PIP4Kgamma sequence, was used to raise a custom polyclonal antibody (NeoMPS, San Diego, CA), which was subsequently purified from rabbit serum by affinity matrix chromatography. Surface plasmon resonance analysis was carried out on a Biacore 3000 instrument (GE Healthcare Life Sciences, Bucks, UK) using two optical biosensor chips: carboxymethylated dextran preimmobilized with nitrilotriacetic acid (NTA) or streptavidin (SA). Purified PIP4K recombinant protein and control 6xHis tag protein were adsorbed to the NTA chip at concentrations of 1-9 ng/mm2. Anti-PIP4Kgamma antibody was passed over the chip at 10 mug/ml to detect specific interaction, and data were normalized to the nonspecific control. Biotinylated anti-PIP4Kgamma and control antibodies were bound to the SA chip, to which PIP4Kgamma was then applied at saturating levels, to show specific antibody-binding interaction.
###end p 20
###begin p 21
###xml 127 129 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1448 1450 1434 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 347 351 <span type="species:ncbi:9925">goat</span>
###xml 458 464 <span type="species:ncbi:9986">rabbit</span>
###xml 530 536 <span type="species:ncbi:9986">rabbit</span>
###xml 597 602 <span type="species:ncbi:10090">mouse</span>
###xml 637 643 <span type="species:ncbi:9986">rabbit</span>
###xml 718 724 <span type="species:ncbi:9986">rabbit</span>
###xml 791 796 <span type="species:ncbi:10090">mouse</span>
###xml 834 838 <span type="species:ncbi:9925">goat</span>
###xml 878 884 <span type="species:ncbi:9986">rabbit</span>
###xml 1121 1132 <span type="species:ncbi:3704">Horseradish</span>
###xml 1438 1441 <span type="species:ncbi:10116">rat</span>
Protein samples (50 mug) were resolved on 10% polyacrylamide gels, and Western blots were carried out as described previously (16), using anti-PIP4Kgamma at 0.5 mug/ml. Anti-PIP4Kgamma was neutralized by saturating with excess of antigenic peptide for 30 min. Other antibodies used in this study were diluted to the manufacturers recommendations: goat polyclonal antibodies to aquaporin 1 (AQP1), aquaporin 2 (AQP2) and Tamm-Horsfall protein, and polyclonal rabbit antibodies to lgp110 (Santa Cruz Biotechnology, Santa Cruz, CA); rabbit polyclonal antibodies to TGN38 were a gift from G. Banting; mouse Mabs to EEA1, BiP, and GM130, and rabbit polyclonal antibodies to p115 (BD Transduction Laboratories, Oxford, UK); rabbit polyclonal antibodies to calreticulin (Calbiochem, La Jolla, CA); mouse Mabs to tubulin (Sigma-Aldrich); and goat polyclonal antibodies to golgin160 and rabbit polyclonal antibodies to catalase, p58K, mannose 6-phosphate receptor, and mannosidase II (Abcam, Cambridge, UK). Alexa Fluor 568 phalloidin and TO-PRO-3 iodide were used to directly stain actin and DNA (Molecular Probes, Paisley, UK). Horseradish peroxidase-conjugated secondary antibodies and SuperSignal West Dura substrate were used for Western blotting (Pierce Protein Research Products, Rockford, IL), and Alexa dye-conjugated secondary antibodies were used for fluorescence microscopy (Molecular Probes). Immunoprecipitation with anti-PIP4Kgamma rat Mabs (16) and protein G-Sepharose (GE Healthcare) was carried out for 16 h at 4degreesC. Beads were washed in cold PBS and used directly for Western blotting or kinase assay.
###end p 21
###begin title 22
Immunocytochemistry and immunohistochemistry.
###end title 22
###begin p 23
Mammalian cells expressing green fluorescent protein-tagged constructs were fixed in 4% paraformaldehyde for 30 min on ice. Cells were permeabilized with 0.1% Triton X-100 in PBS for 10 min and blocked with 4% fish skin gelatin (Sigma-Aldrich) in PBS for 30 min and then incubated for 60 min with primary and secondary antibodies (2% gelatin in PBS) with PBS washes between and after incubation. Slides were mounted using ProLong Gold antifade reagent (Molecular Probes), and images were taken on a Leica TCS SP5 laser scanning confocal microscope running LAS AF software (Leica Microsystems, Wetzlar, Germany). Golgi dissociation was achieved by treatment with Brefeldin A (10 mug/ml in DMEM) for 30 min at 37degreesC.
###end p 23
###begin p 24
###xml 743 749 <span type="species:ncbi:9986">rabbit</span>
Sagittal and horizontal tissue sections for fluorescent labeling were pretreated to reduce autofluorescence (20 min in 1 mg/ml sodium borohydride), blocked for 2 h (1% fish skin gelatin, 0.3% Triton X-100 in PBS), exposed to primary antibody (24 h at 4degreesC), and fluorophore-labeled secondary antibody (4 h) before being mounted as described previously. Confocal images were spectrally separated by LAS AF software using reference spectra obtained from unstained tissue and cells overexpressing green fluorescent protein. Tissue sections for chemical staining were pretreated for 20 min (20% methanol and 5% hydrogen peroxide), blocked, and incubated with primary antibody as described, and then they were incubated with biotinylated anti-rabbit IgG antibodies before visualization using Vectastain ABC and DAB substrate kits (Vector Laboratories, Burlingame, CA). Slides were treated with Histoclear and mounted with DPX reagent (Sigma-Aldrich) before light microscopy.
###end p 24
###begin title 25
Lipid kinase assay.
###end title 25
###begin p 26
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 224 225 223 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 325 327 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 436 438 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
PIP4K assays were carried out as described previously (16) with slight adaptation. Substrate lipid (6 muM PtdIns5P) was dried under vacuum, and micelles were made by sonication in kinase buffer (50 mM Tris pH 7.4, 10 mM MgCl2, 80 mM KCl, and 2 mM EGTA). Recombinant PIP4K was added to the reaction mixture with 10muCi [gamma-32P]ATP for 90 min at 30degreesC. Lipids were extracted and separated by silica-gel thin layer chromatography (16), and results were obtained by autoradiography.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
PIP5K2 isoforms have different expression profiles.
###end title 28
###begin p 29
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2</italic>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 189 205 189 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2A, PIP5K2B</italic>
###xml 211 219 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C,</italic>
###xml 337 343 337 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 532 538 532 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2</italic>
###xml 684 685 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 678 685 675 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 758 765 755 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2A</italic>
###xml 801 808 798 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2B</italic>
###xml 820 827 817 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 898 900 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 960 967 957 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 1170 1171 1167 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1164 1171 1161 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 1199 1206 1196 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 1387 1388 1384 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1381 1388 1378 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
Expression studies using RT-PCR have previously suggested that levels of PIP5K2 transcription are high in different tissues (1, 19). Using a series of isoform-specific PCR primer pairs for PIP5K2A, PIP5K2B, and PIP5K2C, we quantitatively assessed the expressed levels of these transcripts in mRNA isolated from a range of mouse tissues (Fig. 1). Automated quantitative PCR of synthesized cDNA libraries was completed using three biological replicates for each tissue. Pooled data were analyzed by the Livak method (23), normalizing PIP5K2 to the housekeeping gene beta-actin, and values were calculated as the relative fold increase above the lowest observed tissue expression (Fig. 1A). All three isoforms were expressed at higher levels in the brain, with PIP5K2A expression increased in spleen and PIP5K2B in muscle. PIP5K2C was especially high in kidney, as originally reported by Itoh et al. (19). Tissue analysis by in situ hybridization with a range of PIP5K2C probes confirmed that transcription of this isoform was upregulated in brain and kidney, compared with a control tissue, and that the expression was localized to discrete regions of these organs (Fig. 1B). Silver grain labeling of PIP5K2C mRNA in the kidney suggested that expression was confined to segments of the nephron within the cortical and medullary regions and was not present in the kidney vasculature (Fig. 1C).
###end p 29
###begin title 30
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Endogenous PIP4Kgamma is differentially expressed in mouse tissues.
###end title 30
###begin p 31
###xml 237 243 229 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 351 352 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 345 352 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 387 388 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 381 388 362 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 631 632 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 625 632 591 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 952 953 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 946 953 900 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 955 956 909 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1300 1302 1230 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1508 1509 1434 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1502 1509 1428 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1511 1512 1437 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1688 1694 1614 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 1696 1698 1622 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 1839 1840 1761 1762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1833 1840 1755 1762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
A polyclonal peptide antibody to the variable region of PIP4Kgamma was raised and purified. Due to the similarity of the sequence of the PIP4K isoforms at the protein level, the specificity of the antibody for PIP4Kgamma was determined (Fig. 2). The anti-PIP4Kgamma antibody has no cross-reactivity with PIP4Kalpha or PIP4Kbeta by Western blot (Fig. 2A) or by immunocytochemistry (Fig. 2B). Purified recombinant PIP4Ks were bound to an NTA sensor chip by 6xHis tag, and surface plasmon resonance analysis of the binding of anti-PIP4Kgamma antibody indicated specificity for PIP4Kgamma compared with PIP4Kalpha and PIP4Kbeta (Fig. 2C). This was confirmed by binding biotinylated anti-PIP4Kgamma antibody to an SA sensor chip and detecting specific binding to PIP4Kgamma (data not shown). Direct Western blotting of a bank of tissue lysates confirmed the presence of significant endogenous levels of PIP4Kgamma in brain, kidney, ovary, and testis (Fig. 3A, i). Other tissues had little or no detectable levels of PIP4Kgamma, assuming representative expression based on equivalent loading of total lysate protein. Endogenous PIP4Kgamma was detected as two bands of very similar molecular mass of approximately47 kDa, the larger band presumably representing the phosphorylated form of mature PIP4Kgamma (19). Crude kidney fractionation and subsequent Western blotting of protein lysates indicated that PIP4Kgamma was present throughout this organ, but comparatively higher levels were seen in the medulla (Fig. 3B, i). Nonspecific bands were visualized using neutralized antibody as control, and lower molecular mass immunoreactive bands were presumed to be products of proteolytic cleavage (Fig. 3, ii). Interestingly, PIP4Kgamma in heart ran predominantly as a 40-kDa band, suggesting that processing of this isoform may be occurring (Fig. 3A).
###end p 31
###begin title 32
PIP4Kgamma expression in kidney is localized to specific cells.
###end title 32
###begin p 33
###xml 408 409 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 402 409 398 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 697 698 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 691 698 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 766 767 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 760 767 752 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 1239 1240 1225 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1233 1240 1219 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1366 1367 1348 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1360 1367 1342 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
Identification of PIP4Kgamma at a cellular level was shown to be specific by the use of peptide-saturated primary antibody controls, which demonstrated an absence of signal due to nonspecific binding of primary or secondary antibodies in tissue immunohistochemistry. Spectral separation was also utilized to remove significant autofluorescence from the kidney tissue in immunofluorescence experiments (Fig. 4A). Analysis of whole kidney sections confirmed that PIP4Kgamma was expressed throughout this organ (data not shown). Detailed examination of representative regions of the kidney at high resolution indicated that the positive signal was seen to be concentrated in the outer medulla (Fig. 4B), confirming the results obtained for transcript expression (Fig. 1B), with much less signal being observed in the cortical labyrinth. This signal was restricted to whole regions of specific tubules, which could be visualized using sequential confocal imaging at 2-mum intervals throughout a 20-mum cryosectioned tissue slice (data not shown). The PIP4Kgamma-expressing tubules were present in both the cortical medullary rays and the inner and outer stripe of the outer medulla but were absent from the tubules of the inner medulla (Fig. 4B). However, it was possible to observe single PIP4Kgamma-positive cells within tubules in the cortex and inner medulla (Fig. 4B).
###end p 33
###begin p 34
###xml 156 162 152 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 257 263 249 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 265 266 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 271 272 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 323 324 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 317 324 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 418 420 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 586 592 574 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 594 597 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8211;F</italic>
###xml 710 711 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 791 797 771 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 799 800 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 805 806 785 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 845 846 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 839 846 819 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>I</italic></xref>
###xml 919 921 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 1160 1162 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 1281 1287 1249 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 1289 1292 1257 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J&#8211;L</italic>
Costaining sections with selective markers for different nephron regions allowed accurate determination of the tubules and cells that expressed PIP4Kgamma (Fig. 5). The absence of PIP4Kgamma in cortical tubules with a significant brush-border lumen lining (Fig. 5, A and B) or coincident with the water channel AQP1 (Fig. 5C), a marker for the proximal convoluted tubule and thin descending limb of the loop of Henle (29), suggested that expression was restricted to the distal part of the nephron. PIP4Kgamma-positive tubules also expressed Tamm-Horsfall protein in the outer medulla (Fig. 5, D-F), which suggested that PIP4Kgamma is localized to cells in the thick ascending limb (TAL) of the loop of Henle (2). The presence of PIP4Kgamma-positive tubules in the cortex and outer medulla (Fig. 5, G and H), but not in the inner medulla (Fig. 5I), and distinct from tubules expressing the collecting duct marker AQP2 (24), confirmed that PIP4Kgamma was mainly expressed in TAL. Interestingly, isolated PIP4Kgamma-positive cells were also localized to the collecting duct but were spatially differentiated from AQP2, which selectively stained principal cells (24). This suggested that PIP4Kgamma was also localized to intercalated cells in cortical and medullary collecting ducts (Fig. 5, J-L).
###end p 34
###begin title 35
PIP4Kgamma has a distinct subcellular compartmentalization.
###end title 35
###begin p 36
###xml 97 103 93 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6</xref>
###xml 105 106 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 107 108 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 366 367 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 360 367 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>E</italic></xref>
###xml 477 483 467 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6</xref>
###xml 485 486 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 491 492 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 906 912 888 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7</xref>
###xml 1305 1306 1279 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1299 1306 1273 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 1404 1406 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1558 1561 1528 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 1588 1589 1558 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1582 1589 1552 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>B</italic></xref>
###xml 1728 1729 1694 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1722 1729 1688 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f7" ref-type="fig">Fig. 7<italic>C</italic></xref>
Tubule sections of medullary TAL showed a distinct concentration of PIP4Kgamma around the lumen (Fig. 6, A-D). Analysis of a pool of cross-sectioned tubules with a diameter of 23-25 mum gave an average fluorescence profile that indicated a sixfold increase of signal within 3 mum of the apical membrane of tubule cells, compared with the basolateral membrane (Fig. 6E). Higher magnification of these cells suggested that PIP4Kgamma might be present in a vesicular compartment (Fig. 6, C and D). To further investigate this compartmentalization, PIP4Kgamma expression was studied in kidney-derived cell lines, but because endogenous levels of enzyme were not visible by immunocytochemistry in these cells, overexpressed protein levels were required for colocalization experiments. Cells expressing green fluorescent protein-tagged PIP4Kgamma were stained with antibodies against different cellular markers (Fig. 7). PIP4Kgamma was not seen to associate with markers for defined vesicular compartments such as peroxisomes (catalase), endosomes (EEA1, mannose 6-phosphate receptor), or lysosomes (lgp110) or with markers for structural components such as tubulin or actin (data not shown). In our experiments, PIP4Kgamma was also not seen to associate with endoplasmic reticulum markers [calreticulin (Fig. 7A) and BiP] in contrast with the suggested endoplasmic reticulum localization seen by Itoh et al. (19). PIP4Kgamma did, however, show a partial colocalization with a number of Golgi apparatus markers (golgin160, TGN38, p115, and p58K), most notably the cis-Golgi marker GM130 (Fig. 7B). Golgi dispersal by treatment of cells with Brefeldin A still retained partial colocalization of GM130 with the PIP4Kgamma signal (Fig. 7C) but not with mannosidase II, a Golgi lumen protein, suggesting that the association was with the matrix component of this organelle (data not shown).
###end p 36
###begin title 37
Lipid kinase activity of PIP4Kgamma.
###end title 37
###begin p 38
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 262 263 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 256 263 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 492 493 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 486 493 466 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 24 31 <span type="species:ncbi:562">E. coli</span>
PIP4K, overexpressed in E. coli cells and purified by metal-affinity resin chromatography, was used as a source of enzyme for in vitro kinase assays. PIP4K activity was only observed using the PIP4Kalpha isoform as the recombinant PIP4Kgamma was inactive (Fig. 8A). Using immunoprecipitation experiments with recombinant protein, we were able to show that PIP4Kgamma can associate with PIP4Kalpha strongly enough to be selectively purified with a PIP4Kalpha-specific antibody in vitro (Fig. 8B).
###end p 38
###begin title 39
DICUSSION
###end title 39
###begin p 40
In this study, we investigated the expression, localization and associated biological activity of PIP4Kgamma. We discovered a unique and restricted localization for this PIP4K in kidney tissue and suggest that this has implications for the physiological function of this isoform.
###end p 40
###begin p 41
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 393 395 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 397 399 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 523 524 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 570 572 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 665 667 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 1120 1122 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 1124 1126 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
We have shown that the comparative mRNA expression levels of all three isoforms are significant in brain, where they have a different spatial distribution (1). PIP4Kalpha is the most active of the three isoforms in vitro but has a comparably low mRNA expression in most of the tissues that we tested and is the most abundant isoform in the spleen, probably reflecting its role in hematocytes (17, 26). The PIP4Kbeta isoform mRNA is highly expressed in heart and skeletal muscle cells, consistent with initial observations (6) and providing a link to insulin resistance (22). We have confirmed the original observation that PIP4Kgamma is highly expressed in kidney (19) and also observe high mRNA expression levels in brain, heart, and testis compared with other tissues. Our detection of endogenous PIP4Kgamma protein in tissues is consistent with these transcription levels, also suggesting that PIP4Kgamma is abundant in the ovary and may be processed in heart tissue. The distribution of the PIP4Ks across a range of different tissues, and the observed differences in subcellular localization and intrinsic activity (36, 45), would suggest that specialized functions could be attributed to each and hence to the role of PtdIns(5)P in these locations.
###end p 41
###begin p 42
###xml 432 434 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 436 438 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 463 465 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 739 741 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 850 852 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 1005 1006 989 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Peptide analysis of the sequence of PIP4Kgamma predicts that this protein would not be targeted to the endoplasmic reticulum or plasma membrane due to the absence of a recognized signal peptide, which is consistent with our observation that PIP4Kgamma, when overexpressed in cells, is partially colocalized to the structural component of the Golgi apparatus. Roles for PtdIns3P and PtdIns4P in membrane trafficking are established (10, 32), but the recent study (25) of a Golgi-localized phospholipid-inositol phosphatase with a substrate preference for PtdIns5P presents the intriguing possibility that this phosphoinositide is also present in cellular vesicles. PIP4Kgamma also has a role in actin remodeling during endocytic transport (30), and PtdIns5P levels have been associated with this and with vesicle translocation to the plasma membrane (38). PIP4Kgamma could be recruited to the external surface of a specific microsomal compartment to modify the PtdIns5P signal or to synthesize PtdIns(4,5)P2.
###end p 42
###begin p 43
###xml 450 452 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 503 505 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 712 714 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 716 718 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 878 880 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 882 884 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
The restricted expression of PIP4Kgamma within the kidney may be significant within the context of the specialized function of different regions of the nephron. Our experiments indicate that PIP4Kgamma is present in cells constituting the TAL and is also restricted to intercalated cells in the collecting duct and appears to have a similar subcellular localization in these cell types as that recently observed for members of the Arf GTPase family (11), which have known roles in membrane trafficking (34). These regions are predominantly concerned with homeostasis by active ion transport and pH regulation and contain a large number of channels and transporters specific to these tasks (for reviews see Refs. 20, 27). Phosphoinositide regulation of both the trafficking to the plasma membrane and the activity of various collecting duct-localized channels has been reported (14, 44), but a specific role for PIP4Kgamma in this process has yet to be established.
###end p 43
###begin p 44
###xml 107 109 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 155 162 151 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 323 324 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 326 328 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 330 332 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 155 162 <span type="species:ncbi:562">E. coli</span>
PIP4Kgamma has been shown to have PtdIns5P 4-kinase activity when immunoprecipitated from mammalian cells (19), and the recombinant protein, purified from E. coli, is inactive, suggesting that a eukaryotic modification to PIP4Kgamma is required for kinase activation. However, due to the ability of the PIP4Ks to dimerize (4, 16, 35) in vivo, we also cannot rule out the possibility that the observed activity associated to PIP4Kgamma is attributable to PIP4K heterodimers. This raises the possibility that PIP4Kgamma is able to recruit PtdIns5P 4-kinase activity (in the form of PIP4Kalpha) to specific compartments, based on the potential ability to act as a scaffolding protein.
###end p 44
###begin p 45
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The roles of PtdIns5P, PtdIns(4,5)P2, and hence the PIP4Ks, in kidney function are unknown. We have shown that PIP4Kgamma is the predominant PIP4K in the kidney, and we suggest that its role may be related to its specific localization in this organ.
###end p 45
###begin title 46
GRANTS
###end title 46
###begin p 47
This study was supported by a Programme Grant (WT063581) from the Wellcome Trust and the Biotechnology and Biological Sciences Research Council.
###end p 47
###begin p 48
###xml 105 109 <span type="species:ncbi:8233">Tuna</span>
We thank Dr. Patrick Lynch for practical advice, Soren Nielsen for helpful suggestions, and Dr. Mihriban Tuna for technical expertise and analysis of biacore experiments.
###end p 48
###begin title 49
REFERENCES
###end title 49
###begin p 50
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2A</italic>
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2B,</italic>
###xml 99 106 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 178 179 178 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 256 263 256 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2A</italic>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 404 405 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 502 503 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">f</italic>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 612 619 612 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP5K2C</italic>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
###xml 549 554 <span type="species:ncbi:10090">mouse</span>
PIP5K2C is differentially expressed in adult mouse tissues. A: expression of PIP5K2A, PIP5K2B, and PIP5K2C determined by quantitative PCR using the comparative threshold cycle (CT) method. Normalized expression is presented as relative fold increase above PIP5K2A in testis (n = 9). B: in situ hybridization using PIP5K2C-specific probes on thin sections of adult mouse brain (a), liver (b), and kidney (c; not to scale). Control incubations using an excess of cold probe indicate nonspecific binding (d-f). C: autoradiographic emulsion staining of mouse kidney cortex tubules, silver grains (arrows) indicating PIP5K2C mRNA expression (tu, tubule; gl, glomerulus). Scale bar = 20 mum.
###end p 50
###begin p 51
###xml 151 152 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 250 251 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 287 289 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 292 293 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 459 460 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
Specificity of anti-PIP4Kgamma antibody. Detection of PIP4Kgamma, but not the PIP4Kalpha or PIP4Kbeta isoforms, was established in various procedures. A: equivalent amounts of purified recombinant protein of each isoform were visualized on SDS-PAGE (i) and detected by Western blotting (ii). B: HeLa cells overexpressing green fluorescent protein (GFP)-tagged PIP4Kgamma or PIP4Kalpha were fixed and stained with anti-PIP4Kgamma antibody. Scale bar = 10 mum. C: Surface plasmon resonance analysis using PIP4Kalpha, PIP4Kbeta, and PIP4Kgamma adsorbed to an nitrilotriacetic acid biosensor. Anti-PIP4Kgamma antibody was passed over the biosensor at 0 s and exchanged for wash buffer at 45 s. Data were normalized to 6xHis tag control protein binding.
###end p 51
###begin p 52
###xml 103 104 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 178 180 170 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 205 206 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 264 265 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
PIP4Kgamma is expressed in adult mouse tissues. Lysates were probed with PIP4Kgamma-specific antibody (i) and with neutralized antibody after saturation with immunizing peptide (ii). Whole tissue lysates (A) and protein preparations from different kidney regions (B) were probed with the same antibody. Equivalent protein loading was based on total lysate concentration. Purified recombinant PIP4Kgamma was used to identify endogenous PIP4Kgamma at the correct molecular mass (arrow).
###end p 52
###begin p 53
###xml 183 184 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 242 243 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 285 287 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 408 409 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
PIP4Kgamma expression in the adult mouse kidney. Tissue immunohistochemistry using antibody specific to PIP4Kgamma identified the expression of endogenous protein in kidney sections. A: positive PIP4Kgamma signal detected by reporter enzyme (i: scale bar = 10 mum) or epifluorescence (ii; scale bar = 40 mum). Negative control reactions are also shown (primary antibody preincubated with antigenic peptide). B: high resolution imaging indicated that PIP4Kgamma (green) was differentially distributed in the representative kidney regions indicated after removal of autofluorescence. Nuclei (red) are counterstained as contrast. Scale bar = 40 mum.
###end p 53
###begin p 54
###xml 120 121 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 282 283 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 347 348 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 441 444 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8211;F</italic>
###xml 512 513 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 607 610 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G&#8211;L</italic>
###xml 704 705 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 707 708 683 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 786 789 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I&#8211;L</italic>
###xml 800 801 772 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 803 804 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 806 809 778 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8211;F</italic>
###xml 815 816 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 851 852 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 854 857 826 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G&#8211;J</italic>
###xml 863 864 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Endogenous PIP4Kgamma is differentially expressed in the adult mouse nephron. Actin (red) staining of cortical regions (A) identified luminal brush borders (arrow) in proximal tubules (d; distal tubule, p; proximal tubule), and localization of PIP4Kgamma (green) in distal tubules (B). PIP4Kgamma was not coincident with AQP1 (red) in the cortex (C) but was present in Tamm-Horsfall protein (THP; red) positive tubules in the outer medulla (D-F). PIP4Kgamma was also seen in THP-negative tubules in this region (F; arrows). Double staining for PIP4Kgamma (green) and AQP2 (red) in different kidney regions (G-L) revealed tubules positive for PIP4Kgamma but negative for AQP2 in cortex and outer medulla (G, H; arrows). Isolated cells in AQP2-positive tubules also expressed PIP4Kgamma (I-L; arrows). A, B, D-F, and K: images from horizontal sections. C, G-J, and L: images from sagittal sections. Scale bars = 20 mum.
###end p 54
###begin p 55
###xml 246 247 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 249 250 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 316 317 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 322 323 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 440 441 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 510 511 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 513 514 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 168 173 <span type="species:ncbi:10090">mouse</span>
Distribution of PIP4Kgamma in kidney thick ascending limb (TAL) cells in situ. Endogenous PIP4Kgamma was detected in thin sections of the outer medulla region of adult mouse kidney. Saggital kidney section shows longitudinal TAL tubule sections (A, C), and horizontal kidney section shows TAL tubule cross-sections (B and D). Scale bars = 10 mum. Statistical analysis of PIP4Kgamma distribution across TAL tubule cross-sections (such as in B), by fluorescence intensity, indicated peaks in the luminal region (E; n = 25).
###end p 55
###begin p 56
###xml 330 331 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 379 382 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 403 404 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 507 508 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
Overexpressed PIP4Kgamma localizes to a specific cellular compartment. Transiently transfected cells, expressing GFP-tagged PIP4Kgamma (green), were costained with antibodies to specific markers for different cellular compartments (red). No specific colocalization was observed with the endoplasmic reticulum marker calreticulin (A). Partial colocalization was observed with the cis-Golgi marker GM130 (B),and this juxtaposed labeling was maintained during Golgi dissociation by treatment with Brefeldin A (C). Scale bars = 10 mum.
###end p 56
###begin p 57
###xml 144 145 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 258 259 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 261 262 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 560 561 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 583 585 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
Activity and binding characteristics of recombinant PIP4Ks. PIP4Kalpha and PIP4Kgamma recombinant protein was purified from a bacterial source. A: PIP4K assay using equivalent amounts of recombinant protein from each PIP4K, showing generation of PtdIns(4,5)P2. B: immunoprecipitation (IP) of recombinant PIP4K protein using PIP4Kalpha-specific antibody. IPs are from equivalent amounts of PIP4Kalpha, PIP4Kgamma, or a mixture of the 2 isoforms, in buffer. Control IP contains no recombinant protein. Western blots (WB) were probed with either anti-PIP4Kalpha (i) or anti-PIP4Kgamma (ii). Recombinant protein markers (rec) indicate PIP4K-positive bands (65 kDa).
###end p 57

